Found: 285
Select item for more details and to access through your institution.
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 912, doi. 10.1111/head.14797
- By:
- Publication type:
- Article
VPAC1 and VPAC2 receptors mediate tactile hindpaw hypersensitivity and carotid artery dilatation induced by PACAP38 in a migraine relevant mouse model.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01830-2
- By:
- Publication type:
- Article
Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 6, p. 612, doi. 10.1001/jamadermatol.2024.0408
- By:
- Publication type:
- Article
Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial.
- Published in:
- Cephalalgia, 2024, v. 44, n. 5, p. 1, doi. 10.1177/03331024241248211
- By:
- Publication type:
- Article
Effects of PDE-3 inhibition in persistent post-traumatic headache: evidence of cAMP-dependent signaling.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, p. 1, doi. 10.1186/s10194-024-01762-x
- By:
- Publication type:
- Article
Effects of PDE-3 inhibition in persistent post-traumatic headache: evidence of cAMP-dependent signaling.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01762-x
- By:
- Publication type:
- Article
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 339, doi. 10.1007/s40120-023-00575-5
- By:
- Publication type:
- Article
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01736-z
- By:
- Publication type:
- Article
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury.
- Published in:
- Cephalalgia, 2024, v. 44, n. 3, p. 1, doi. 10.1177/03331024241234068
- By:
- Publication type:
- Article
Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura.
- Published in:
- Cephalalgia, 2024, v. 44, n. 3, p. 1, doi. 10.1177/03331024241237247
- By:
- Publication type:
- Article
Postdromal symptoms in migraine: a REFORM study.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01716-3
- By:
- Publication type:
- Article
Clinical features of migraine with aura: a REFORM study.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01718-1
- By:
- Publication type:
- Article
Premonitory symptoms in migraine: A REFORM Study.
- Published in:
- Cephalalgia, 2024, v. 44, n. 2, p. 1, doi. 10.1177/03331024231223979
- By:
- Publication type:
- Article
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 2, p. 1, doi. 10.1111/ene.16131
- By:
- Publication type:
- Article
Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial.
- Published in:
- Cephalalgia, 2024, v. 44, n. 1, p. 1, doi. 10.1177/03331024231222916
- By:
- Publication type:
- Article
Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 12, p. 5224, doi. 10.1093/brain/awad261
- By:
- Publication type:
- Article
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?
- Published in:
- Cephalalgia, 2023, v. 43, n. 12, p. 1, doi. 10.1177/03331024231218392
- By:
- Publication type:
- Article
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01688-w
- By:
- Publication type:
- Article
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 11, p. 1, doi. 10.1177/03331024231214987
- By:
- Publication type:
- Article
Lack of reproducibility of resting-state functional MRI findings in migraine with aura.
- Published in:
- Cephalalgia, 2023, v. 43, n. 11, p. 1, doi. 10.1177/03331024231212574
- By:
- Publication type:
- Article
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1351, doi. 10.1111/head.14651
- By:
- Publication type:
- Article
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01666-2
- By:
- Publication type:
- Article
An exploratory analysis of clinical and sociodemographic factors in CGRP-induced migraine attacks: A REFORM study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 10, p. 1, doi. 10.1177/03331024231206375
- By:
- Publication type:
- Article
What proportion of people with migraine report postdromal symptoms? A systematic review and meta-analysis of observational studies.
- Published in:
- Cephalalgia, 2023, v. 43, n. 10, p. 1, doi. 10.1177/03331024231206376
- By:
- Publication type:
- Article
Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01664-4
- By:
- Publication type:
- Article
Calcitonin gene-related peptide causes migraine aura.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01656-4
- By:
- Publication type:
- Article
Calcitonin gene-related peptide causes migraine aura.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01656-4
- By:
- Publication type:
- Article
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
- Published in:
- Cephalalgia, 2023, v. 43, n. 9, p. 1, doi. 10.1177/03331024231190296
- By:
- Publication type:
- Article
Correction: PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01604-2
- By:
- Publication type:
- Article
Investigations of the subarachnoid space as a potential link between aura and headache in migraine: A case-control MRI study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 6, p. 1, doi. 10.1177/03331024231170541
- By:
- Publication type:
- Article
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 6, p. 730, doi. 10.1111/head.14536
- By:
- Publication type:
- Article
The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01599-w
- By:
- Publication type:
- Article
Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1135246
- By:
- Publication type:
- Article
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 5, p. 1, doi. 10.1177/03331024231170807
- By:
- Publication type:
- Article
Prolactin in headache and migraine: A systematic review of preclinical studies.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 5, p. 577, doi. 10.1111/head.14412
- By:
- Publication type:
- Article
Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial.
- Published in:
- Cephalalgia, 2023, v. 43, n. 4, p. 1, doi. 10.1177/03331024231161745
- By:
- Publication type:
- Article
Correction: Investigation of cortical thickness and volume during spontaneous attacks of migraine without aura: a 3-Tesla MRI study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Prolactin in headache and migraine: A systematic review of clinical studies.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221136286
- By:
- Publication type:
- Article
Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221143773
- By:
- Publication type:
- Article
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review.
- Published in:
- Cephalalgia, 2023, v. 43, n. 1, p. 1, doi. 10.1177/03331024221131337
- By:
- Publication type:
- Article
Migraine aura‐like episodes following sclerotherapy for varicose veins of the lower extremities—A systematic review.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 1, p. 40, doi. 10.1111/head.14448
- By:
- Publication type:
- Article
Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 1, p. 79, doi. 10.1111/head.14439
- By:
- Publication type:
- Article
PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01523-8
- By:
- Publication type:
- Article
Debate: Are cluster headache and migraine distinct headache disorders?
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01504-x
- By:
- Publication type:
- Article
Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01510-z
- By:
- Publication type:
- Article
The role of high‐conductance calcium‐activated potassium channel in headache and migraine pathophysiology.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 5, p. 347, doi. 10.1111/bcpt.13787
- By:
- Publication type:
- Article
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1 st edition.
- Published in:
- Cephalalgia, 2022, v. 42, n. 11/12, p. 1099, doi. 10.1177/03331024221099035
- By:
- Publication type:
- Article
Cluster headache – The worst possible pain on YouTube.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1222, doi. 10.1111/head.14368
- By:
- Publication type:
- Article